Who Dies From Prostate Cancer? An Analysis of the Surveillance, Epidemiology and End Results Database
- 1 September 2019
- journal article
- research article
- Published by Elsevier in Clinical Oncology
- Vol. 31 (9) , 630-636
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active SurveillanceEuropean Urology, 2014
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate CancerNew England Journal of Medicine, 2013
- Causes of death in men with prostate cancer: an analysis of 50 000 men from the Thames Cancer RegistryBJU International, 2013
- Long-term Outcomes Among Noncuratively Treated Men According to Prostate Cancer Risk Category in a Nationwide, Population-based StudyEuropean Urology, 2013
- Increased Survival with Enzalutamide in Prostate Cancer after ChemotherapyNew England Journal of Medicine, 2012
- Abiraterone and Increased Survival in Metastatic Prostate CancerNew England Journal of Medicine, 2011
- A Competing-Risks Analysis of Survival After Alternative Treatment Modalities for Prostate Cancer Patients: 1988–2006European Urology, 2011
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trialThe Lancet, 2010
- Radical Prostatectomy Versus Watchful Waiting in Localized Prostate Cancer: the Scandinavian Prostate Cancer Group-4 Randomized TrialJNCI: Journal of the National Cancer Institute, 2008
- Survival Associated With Treatment vs Observation of Localized Prostate Cancer in Elderly MenJAMA, 2006